13D/13G Filings - VIVO VENTURES VII LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-13
8:46 pm
Sale
2024-09-30 13G Verona Pharma plc
VRNA
VIVO VENTURES VII LLC 20,252,688
3.100%
-2,889,512decrease
(-12.49%)
Filing
History
2023-02-13
5:47 pm
Purchase
2022-12-31 13G Verona Pharma plc
VRNA
VIVO VENTURES VII LLC 23,142,200
3.800%
23,142,200increase
(New Position)
Filing
History
2021-11-01
4:30 pm
Purchase
2021-10-25 13G Minerva Surgical, Inc.
UTRS
VIVO VENTURES VII LLC 110,783
7.800%
110,783increase
(New Position)
Filing
History